Presima Securities ULC Increases Stock Holdings in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Presima Securities ULC increased its holdings in Sabra Healthcare REIT, Inc. by 13.9%, reaching a stake worth $17.36 million, representing about 3.9% of its total portfolio.
• Multiple analysts have raised their price targets for Sabra Healthcare REIT, with a consensus average target price of $20.71, indicating a generally positive outlook on the stock.
• Sabra Healthcare REIT recently announced a quarterly dividend of $0.30 per share, translating to a dividend yield of 6.3%, although the company's dividend payout ratio stands at 157.89%.

Presima Securities ULC grew its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 13.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 993,688 shares of the real estate investment trust's stock after purchasing an additional 121,323 shares during the quarter. Sabra Healthcare REIT makes up 3.9% of Presima Securities ULC's holdings, making the stock its 11th biggest holding. Presima Securities ULC owned approximately 0.42% of Sabra Healthcare REIT worth $17,360,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in SBRA. SVB Wealth LLC acquired a new position in shares of Sabra Healthcare REIT in the first quarter worth approximately $34,000. UMB Bank n.a. boosted its holdings in shares of Sabra Healthcare REIT by 379.6% during the 1st quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock worth $36,000 after buying an additional 1,621 shares in the last quarter. Wealth Preservation Advisors LLC bought a new position in shares of Sabra Healthcare REIT during the 1st quarter worth approximately $38,000. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Sabra Healthcare REIT by 61.2% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 2,806 shares of the real estate investment trust's stock worth $49,000 after buying an additional 1,065 shares in the last quarter. Finally, Assetmark Inc. boosted its holdings in shares of Sabra Healthcare REIT by 37.8% during the 1st quarter. Assetmark Inc. now owns 3,607 shares of the real estate investment trust's stock worth $63,000 after buying an additional 989 shares in the last quarter. 99.40% of the stock is owned by institutional investors and hedge funds.

Sabra Healthcare REIT Stock Performance

Shares of NASDAQ:SBRA traded down $0.01 during mid-day trading on Friday, reaching $19.13. 588,751 shares of the company traded hands, compared to its average volume of 2,431,641. The company's 50 day moving average price is $18.68 and its 200-day moving average price is $17.95. The firm has a market cap of $4.59 billion, a PE ratio of 25.19, a PEG ratio of 1.51 and a beta of 0.88. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80. Sabra Healthcare REIT, Inc. has a 52 week low of $15.60 and a 52 week high of $20.03.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.02. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The business had revenue of $189.15 million for the quarter, compared to analysts' expectations of $185.64 million. During the same period in the prior year, the firm earned $0.36 EPS. The company's revenue for the quarter was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. On average, equities analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Friday, August 15th were issued a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.3%. Sabra Healthcare REIT's payout ratio is 157.89%.

Analyst Upgrades and Downgrades

SBRA has been the subject of a number of analyst reports. BMO Capital Markets increased their price target on Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a research report on Monday, August 25th. Scotiabank increased their price objective on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a report on Monday, June 23rd. JMP Securities increased their price objective on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a report on Wednesday, August 6th. Wells Fargo & Company increased their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an "overweight" rating in a report on Wednesday, August 27th. Finally, Truist Financial increased their price objective on Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a "hold" rating in a report on Tuesday, September 2nd. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, Sabra Healthcare REIT presently has an average rating of "Moderate Buy" and a consensus price target of $20.71.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.